Biotech and Pharmaceutical Industry Events & Conferences

Summary

Stem cells are being developed for use as therapies for many diseases. They also have strong potential for use in drug discovery, finding applications in toxicology testing and understanding disease mechanisms for novel target identification. The potential for this research is huge, and companies need to arm themselves with essential scientific knowledge alongside the necessary business understanding in this field.

SMi's 2nd Annual Stem Cells conference brings together leading pharmaceutical companies and smaller biotechs working in regenerative medicine to discuss the scientific advances and future business opportunities offered by stem cell research. Don't miss your chance to network with the leaders in this field, and look towards the future of this rapidly expanding area of medicine.

For more information visit: http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3185

Summary

Opal Events is proud to present our next exciting conference Medical Devices Summit 2010 which will highlight hot button issues in the medical devices industry.

There will be a strong focus on key regulations and strategies in compliance to help avoid costly design and production mistakes.

This devices conference provides the latest regulatory news and regional regulations update, software validation rules, and pre-and post-market requirements. Our conference will have key discussions on medical devices in the US as well as around the globe.

Learn tips and strategies from our expert speaker faculty to streamline your medical devices approval process and pass facility inspection today!

Contact: Marketing@opalgroup.net

For more information visit: http://www.opalevents.org/trk/mbd0903.html

Summary

The continued emergence of antibacterial resistant strains of bacteria is placing an increasingly heavy burden on the world's health services and is having a dramatic effect on global health.

 

There is a real need to develop new antimicrobials to combat this increasing threat; however as highlighted by the recent ECDC/EMEA Technical Report - The bacterial challenge: time to react – “Industry's pipeline contains very few new antibiotics active against multidrug-resistant bacteria. Without stimulating research and development into new antibiotics, an increasing number of infected patients will be without effective treatment".

 

This conference will bring you up to date with new and emerging products in the antimicrobials market, with a particular focus on antibacterials and antifungals and allow you to learn from and network with some of the leading individuals and organisations in this important area.

 

Key topics include:

·           A global update on emerging antibiotic resistant pathogens 

·            Developments in the emerging global challenge of bacterial multi-drug resistance 

·            Tackling resistance in gram-negative bacteria 

·            Forming strategic alliances with large pharma to develop new antibacterials 

·            New approaches to fungal and protozoal infections  

·            Insights into novel therapies for overcoming resistance

 

Click here to register online and save £100: http://www.smi-online.co.uk/2010superbugs10.asp

Alternatively contact Zain Philbey on tel: +44 (0)20 7827 6722

Or Email: zphilbey@smi-online.co.uk

Remember to quote “Report Buyer” and Save £100

 

For more information visit: http://www.smi-online.co.uk/2010superbugs10.asp

Summary

Join us for SMi's 6th annual Accelerating Patient Recruitment & Retention in Clinical Trials. Delve into the latest developments in patient recruitment and retention and learn how the Internet and social media can be utilised to enhance your recruitment and retention with interactive sessions aimed at voicing multiple points of view and experiences.

 

Patient recruitment and retention are critical to drug development programs. Patient recruitment if not adequately planned for can extend development time-lines by a number of years. Retention of patients throughout the life of a clinical trial is essential in order have complete data sets for analysis and subsequent filings.

 

Patient recruitment now takes up 23% of the total clinical trial timeline and, worryingly, this percentage is rising. The industry needs a front-line assessment of how things work in the physician's office, what motivates patients, how pharmaceutical service providers perform, and data on the most effective techniques for patient recruitment and retention; this conference aims to deliver just that.

 

Click here to register online and save £100: http://www.smi-online.co.uk/2010patientrecruit9.asp

Alternativly contact Daniel Davies Tel. +44 (0) 20 7827 6060

Or e-mail: ddavies@smi-online.co.uk

Remember to quote “Report Buyer” and Save £100

 

 

 

For more information visit: http://www.smi-online.co.uk/2010patientrecruit9.asp

Summary

Today, more than ever before, supply chain managers must focus on cost-cutting, outsourcing logistics, improving customer service along the supply chain, improving supply chain agility, safety and visibility, all while remaining compliant with changing regulations.

 

In its 9th year, LogiPharma is the event that most senior level pharmaceutical decision makers attend and here is why:

-          You will be able to gain real life practical applications from 20+ NEW Speakers,  25+ NEW Case Studies

-          Network with industry peers with Roundtable Discussions on key industry initiatives

-          Take a deep dive with a Focus Day on Improving Supply Chain Agility

-          Dig deep with 4 Interactive Workshops

-          Be the first to hear the results of the EFPIA pilot results to understand serialization proposal and determine timeline for implementation

-          Examine a FRESH Case Study from Sandoz Turkey, the first country in the world to mandate serialization of pharma products!

 

Join over 200 supply chain Heads and Directors from leading pharma companies like Pfizer, Bristol-Myers Squibb, Amgen, UCB, and Teva who attend this event every year!

 

For more information: download the brochure on www.logipharmaeurope.com, call +44 (0)207 368 9465 or email info@wbr.co.uk.

For more information visit: http://www.logipharmaeurope.com